Sanuja Bose

Sanuja Bose

Auto-generated profile, based on publicly available information

Sanuja Bose

Division of Vascular Surgery and Endovascular Therapy (S.B., D.P.S., J.H.B., C.W.H.), Johns Hopkins University School of Medicine, Baltimore, MD

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Health Affairs
Verified
Journal Article
Closed access
SBSanuja Bose
Sanuja Bose
CDChen Dun
Chen Dun
GZGeorge Q. Zhang
George Q. Zhang
CWChristi Walsh
Christi Walsh
MMMartin A. Makary
Martin A. Makary
CHCaitlin W. Hicks
Caitlin W. Hicks
Anticipating a growing need for health care during the COVID-19 pandemic, the Centers for Medicare and Medicaid Services expanded telemedicine coverage in the United States on March 6, 2020. In this study we used roughly thirty million Medicare fee-for-service claims to quantify outpatient telemedicine use before and after the Medicare telemedicine coverage waiver and to examine the association of telemedicine use with the Area Deprivation Index, a comprehensive measure of neighborhood socioeconomic disadvantage. Before the waiver, 0.42 percent of patients had at least one outpatient telemedicine visit, with no significant differences between people residing in the most versus the least disadvantaged neighborhoods. With the waiver, 9.97 percent of patients had at least one outpatient telemedicine visit, with the highest odds of utilization seen for people residing in the most disadvantaged neighborhoods. After adjustment, our data suggest that the coverage waiver increased access to telemedicine for all Medicare populations, including people residing in the most disadvantaged neighborhoods, although the odds of use were persistently lower with increasing age. Overall, these findings are encouraging, but they illuminate a need for targeted interventions to improve telemedicine access further.

31 March 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
GZGeorge Q. Zhang
George Q. Zhang
SBSanuja Bose
Sanuja Bose
DSDavid P. Stonko
David P. Stonko
CAChristopher J. Abularrage
Christopher J. Abularrage
DZDevin S. Zarkowsky
Devin S. Zarkowsky
CHCaitlin W. Hicks
Caitlin W. Hicks

1 September 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
SBSanuja Bose
Sanuja Bose
CDChen Dun
Chen Dun
RSRebecca Sorber
Rebecca Sorber
DSDavid P. Stonko
David P. Stonko
ASAlex J. Solomon
Alex J. Solomon
CHCaitlin W. Hicks
Caitlin W. Hicks

16 July 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
CDChen Dun
Chen Dun
DSDavid P. Stonko
David P. Stonko
SBSanuja Bose
Sanuja Bose
AKAlana C. Keegan
Alana C. Keegan
KMKatherine M. McDermott
Katherine M. McDermott
CHCaitlin W. Hicks
Caitlin W. Hicks
Background: Previous cross‐sectional studies have identified wide practice pattern variations in the use of peripheral vascular interventions (PVIs) for the treatment of claudication. However, there are limited data on longitudinal practice patterns. We aimed to describe the temporal trends and charges associated with PVI use for claudication over the past 12 years in the United States. Methods and Results: We conducted a retrospective analysis using 100% Medicare fee‐for‐service claims data to identify all patients who underwent a PVI for claudication between January 2011 and December 2022. We evaluated the trends in utilization and Medicare‐allowed charges of PVI according to anatomic level, procedure type, and intervention settings using generalized linear models. Multinomial logistic regressions were used to evaluate factors associated with different levels and types of PVI. We identified 599 197 PVIs performed for claudication. The proportional use of tibial PVI increased 1.0% per year, and atherectomy increased by 1.6% per year over the study period. The proportion of PVIs performed in ambulatory surgical centers/office‐based laboratories grew at 4% per year from 12.4% in 2011 to 55.7% in 2022. Total Medicare‐allowed charges increased by $11 980 035 USD/year. Multinomial logistic regression identified significant associations between race and ethnicity and treatment setting with use of both atherectomy and tibial PVI. Conclusions: The use of tibial PVI and atherectomy for the treatment of claudication has increased dramatically in in ambulatory surgical center/office‐based laboratory settings, non‐White patients, and resulting in a significant increase in health care charges. There is a critical need to improve the delivery of value‐based care for the treatment of claudication.

20 June 2024 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
TTTerrence C. Tsou
Terrence C. Tsou
CDChen Dun
Chen Dun
SBSanuja Bose
Sanuja Bose
KMKatherine M. McDermott
Katherine M. McDermott
MWMidori White
Midori White
CHCaitlin W. Hicks
Caitlin W. Hicks

12 October 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
SBSanuja Bose
Sanuja Bose
DSDavid P. Stonko
David P. Stonko
GPGeorgina M. Pappas
Georgina M. Pappas
LDLaura M. Drudi
Laura M. Drudi
MSMichael C. Stoner
Michael C. Stoner
CHCaitlin W. Hicks
Caitlin W. Hicks